More importantly, the expression of IL1B induced hyper-activation of IL-1R1-expressing mast cells, while the treatment of anti-IL1B antibody can reduce the aggravation of dermatitis in spontaneous mice models of AD with a defective skin barrier [27]. This evidence concerns the gene IL1R1 and skin disorder.